Facilitating EMA binding test performance using fluorescent beads combined with next‐generation sequencing

The eosin‐5′‐maleimide (EMA) binding test is widely used as diagnostic test for hereditary spherocytosis (HS), one of the most common haemolytic disorders in Caucasian populations. We recently described the advantages of replacing the use of healthy control blood samples with fluorescent beads in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Glenthøj, Andreas, Brieghel, Christian, Nardo‐Marino, Amina, van Wijk, Richard, Birgens, Henrik, Petersen, Jesper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Sickle Cell, Thrombosis, and Benign Haematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176113/
https://www.ncbi.nlm.nih.gov/pubmed/35845192
http://dx.doi.org/10.1002/jha2.277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176113/
https://www.ncbi.nlm.nih.gov/pubmed/35845192
http://dx.doi.org/10.1002/jha2.277

Ejemplares similares